title: Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
abstract: Colorectal cancer is one of the most common malignancies in the Western world. Most colorectal cancers show fluorodeoxyglucose (FDG) uptake, although in mucinous adenocarcinoma uptake may be limited. A literature search was conducted regarding the impact of FDG-PET/computed tomography (CT) on management and outcome in patients with colorectal carcinoma. FDG-PET/CT can have a significant clinical impact on patient management in various stages of the disease. In patients with suspected recurrent disease and patients with liver metastases who might be eligible for surgery FDG-PET/CT can have more benefit than conventional imaging. FDG-PET/CT can be a useful modality to monitor treatment response.
authors.affiliation: Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, Nijmegen 6500HB, The Netherlands.
authors.forename: Sander Thomas
authors.initials: ST
authors.lastname: Laurens
authors.affiliation: Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, Nijmegen 6500HB, The Netherlands. Electronic address: wim.oyen@radboudumc.nl.
authors.forename: Wim J G
authors.initials: WJ
authors.lastname: Oyen
mesh_terms: D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000556:secondary; D064847:Multimodal Imaging / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000473:pathology; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Colorectal carcinoma; FDG-PET/CT; Patient management; Survival outcome